InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Gould Robert J, Director. Insider active across 1 company, notably Fulcrum Therapeutics, Inc.. Aggregated, 9 disclosures have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €662k. History available since 1 April 2022. The latest transaction was filed on 2 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Gould Robert J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
15,000 股@ US$10.87260.031% mcap7.8% 占其流量Common StockSEC:0001193125-26-037606:0
15,000 股@ US$10.72380.030% mcap7.6% 占其流量Common StockSEC:0001193125-26-037573:0
15,000 股@ US$11.87260.034% mcap8.5% 占其流量Common StockSEC:0001193125-26-004572:0
15,000 股@ US$11.0339.0% 占其流量Common StockSEC:0001193125-25-291392:0
6,766 股@ US$15.005.0% 占其流量Common StockSEC:0000899243-23-001803:0
71,435 股@ US$7.840.12% mcap29.4% 占其流量Common StockSEC:0000899243-22-021530:0
16,689 股@ US$7.840.027% mcap6.8% 占其流量Common StockSEC:0000899243-22-021250:0
5,631 股@ US$7.840.0091% mcap2.3% 占其流量Common StockSEC:0000899243-22-014438:0
34,464 股@ US$7.840.055% mcap13.7% 占其流量Common StockSEC:0000899243-22-013881:0
9 条申报中的 9 条
About Gould Robert J
Robert J. Gould is a Director at Fulcrum Therapeutics, Inc. He contributes to the governance of the company and strategic decision-making. Robert brings his expertise in biotechnology to help Fulcrum innovate and grow in the market.
